EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A novel index combining fecal immunochemical test, DNA test, and age improves detection of advanced colorectal adenoma

Yukari Inoue, Akiyo Ishiguro, Yutaka Suehiro iD, Yuki Kunimune, Yuko Yamaoka, Shinichi Hashimoto, Katsuhiko Nakamura, Atsushi Goto, Koichi Hamabe, Toshihiko Matsumoto, Shinobu Tomochika, Shingo Higaki und 13 weitere

Cancer Science · 2024

DOI: 10.1111/cas.16322 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Yukari Inoue und 24 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Yamaguchi University School of Medicine, Ube, Japan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Adenoma, Feces, DNA Methylation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although the fecal immunochemical test for hemoglobin (FIT) is a widely used screening test for colorectal cancer, it is not sensitive enough to detect advanced colorectal adenoma. To address this issue, we performed this study to investigate whether combining the FIT and fecal DNA testing of methylated somatostatin ( SST ) could improve diagnostic performance for advanced colorectal adenoma. We collected feces from 79 healthy subjects with negative results on colonoscopy, 43 patients with non‐advanced colorectal adenoma, 117 patients with advanced colorectal adenoma, and 126 patients with colorectal cancer. After fecal DNA was incubated with methylation‐sensitive restriction enzymes, SST methylation levels were measured by droplet digital PCR. Using logistic multivariate analysis, we established a prediction formula for detecting colorectal neoplasia and named it the FAMS (FIT, age, methylated SST ) index. The diagnostic performance of a single use of FIT for advanced colorectal adenoma showed a sensitivity of 29.1% (34/117) and specificity of 89.3% (109/122). In contrast, the FAMS index showed a sensitivity of 56.4% (66/117) at a similar specificity point of 91.0% (111/122). Furthermore, even at the higher specificity point of 94.3% (115/122), the sensitivity was still higher than that of FIT, reaching 42.7% (50/117). As the FAMS index showed better diagnostic performance for advanced colorectal adenoma than a single use of FIT, the FAMS index could be a promising tool for detecting advanced colorectal adenoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsAdenomaFecesDNA MethylationHumansFemaleMaleMiddle AgedAgedSensitivity and SpecificityEarly Detection of CancerSomatostatinHemoglobinsAdultOccult BloodBiomarkers, TumorAge FactorsAged, 80 and overColonoscopy

Stichwörter der Autor:innen

SSTadvanced colorectal adenomafecal DNA testfecal immunochemical test for hemoglobinmethylation

Substanzen

SomatostatinHemoglobinsBiomarkers, Tumor

Autor:innen und Institutionen

  • Faculty of Medicine, Yamaguchi University School of Medicine, Ube, Japan.
  • Department of Oncology and Laboratory Medicine, Yamaguchi University Graduate School of Medicine, Ube, Japan.
  • Division of Laboratory, Yamaguchi University Hospital, Ube, Japan.
  • Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Ube, Japan.
  • Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan.
  • Department of Gastroenterology, St. Hill Hospital, Ube, Japan.

ORCID-Profile: Yutaka Suehiro, Hiroaki Nagano

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Inoue, Y., Ishiguro, A., Suehiro, Y., Kunimune, Y., Yamaoka, Y., Hashimoto, S., Nakamura, K., Goto, A., Hamabe, K., Matsumoto, T., Tomochika, S., Higaki, S., Fujii, I., Suzuki, C., Koga, M., Tsutsumi, T., Lim, L. A., Matsubara, Y., Yotsuyanagi, H., …, & Yamasaki, T. (2024). A novel index combining fecal immunochemical test, DNA test, and age improves detection of advanced colorectal adenoma. Cancer Science. https://doi.org/10.1111/cas.16322

Vancouver

Inoue Y, Ishiguro A, Suehiro Y, Kunimune Y, Yamaoka Y, Hashimoto S, et al. A novel index combining fecal immunochemical test, DNA test, and age improves detection of advanced colorectal adenoma. Cancer Science. 2024. doi:10.1111/cas.16322

BibTeX
@article{Inoue2024,
  author = {Inoue, Yukari and Ishiguro, Akiyo and Suehiro, Yutaka and Kunimune, Yuki and Yamaoka, Yuko and Hashimoto, Shinichi and Nakamura, Katsuhiko and Goto, Atsushi and Hamabe, Koichi and Matsumoto, Toshihiko and Tomochika, Shinobu and Higaki, Shingo and Fujii, Ikuei and Suzuki, Chieko and Koga, Michiko and Tsutsumi, Takeya and Lim, Lay Ahyoung and Matsubara, Yasuo and Yotsuyanagi, Hiroshi and Nagano, Hiroaki and Yamamoto, Naoki and Sakaida, Isao and Takami, Taro and Nishioka, Mitsuaki and Yamasaki, Takahiro},
  title = {A novel index combining fecal immunochemical test, DNA test, and age improves detection of advanced colorectal adenoma},
  journal = {Cancer Science},
  year = {2024},
  doi = {10.1111/cas.16322}
}
Kostenlos starten →